Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 2,000 shares at $23.04 ($46K) on 2020-01-22, disclosed to the SEC on 2020-01-23.
Scheduled sale ($46k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |